Raffaele Baffa, M.D., PhD

Raffaele Baffa is a seasoned oncology drug development leader with over 20 years of experience advancing innovative therapies across global biopharma. He has led clinical and translational strategies for antibody-drug conjugates, CAR-T therapies, and immuno-oncology programs, contributing to multiple INDs and global regulatory approvals, including U.S. BLA and China NDA filings. Raffaele has built and led cross-functional teams spanning Clinical Development, Translational Medicine, Regulatory, and Medical Affairs, and has played a key role in strategic partnerships, BD, and M&A across companies including Pfizer, Sanofi, Servier Pharmaceuticals, and CARsgen Therapeutics.